CAMERON A MAZZA

Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner SANTA MONICA, CA NPI 1619614922

General Payments — all program years on this page

$587.04

  • Category: General Payments
  • Program years: PY2024
  • Record count: 22
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $587.04 across 22 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $587.0422

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2024 $587.0422

Records — PY2024 (22)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1086290944 Bayer Healthcare Pharmaceuticals Inc. $24.28 08/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1086329506 Bayer Healthcare Pharmaceuticals Inc. $15.89 08/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087137420 Novartis Pharmaceuticals Corporation $30.01 03/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1100392516 Novo Nordisk Inc $22.70 06/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1100509743 Novo Nordisk Inc $13.67 05/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104358995 AstraZeneca Pharmaceuticals LP $20.91 08/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104365353 AstraZeneca Pharmaceuticals LP $17.28 04/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104445607 AstraZeneca Pharmaceuticals LP $20.66 11/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105815257 AstraZeneca Pharmaceuticals LP $20.91 10/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1115912269 Amgen Inc. $18.49 09/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1115912277 Amgen Inc. $21.48 10/28/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131445325 PFIZER INC. $22.70 02/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131531126 PFIZER INC. $26.15 08/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131536968 PFIZER INC. $30.46 03/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131538364 PFIZER INC. $27.55 07/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131555165 PFIZER INC. $14.16 10/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131566440 PFIZER INC. $28.46 09/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131579660 PFIZER INC. $24.16 07/01/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135612090 Lilly USA, LLC $16.63 05/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139983452 GENZYME CORPORATION $120.33 05/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139983476 SANOFI-AVENTIS U.S. LLC $23.79 11/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1141735865 Merck Sharp & Dohme LLC $26.37 07/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.